Cilostazol/Rosuvastatin Calcium

西洛他唑/瑞舒伐他汀钙

Report date: 2024/06/11 13:54:53
NME

Base Information

Drug NameCilostazol/Rosuvastatin Calcium
Drug Alias NameCilo Duo
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodiesterase 3 inhibitorsHMG-CoA reductase inhibitors
TargetsPhosphodiesterase 3HMG-CoA reductase
Therapy Area/IndicationsArterial Occlusive Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
Global Highest StatusNDA/BLA
Highest Status in ChinaN/A
Originator CompaniesKorea United Pharm Inc
China Registration ClassN/A

Develop Information

Active CompaniesKorea United Pharm Inc
Inactive CompaniesN/A
Active IndicationsArterial Occlusive Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A